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Abstract
Background: The quality of life in patients with various chronic disorders, including diabetes has been directly
affected by depression. Depression makes patients less likely to manage their self-care regimens. Accurate
assessment of depression in diabetic populations is important to the treatment of depression in this group and
may improve diabetes management. To our best knowledge, there are few studies that have looked for utilizing
questionnaires in screening for depression among patients with diabetes in Iran. Therefore the aim of this study
was to assess the efficacy and accuracy of the Center for Epidemiological Studies Depression (CES-D) scale and the
Patient Health Questionnaire-9 (PHQ-9), in comparison with clinical interview in people with type 2 diabetes.
Methods: Outpatients who attended diabetes clinics at IEM were recruited on a consecutive basis between
February 2009 and July 2009. Inclusion criteria included patients with type 2 diabetes who could fluently read and
speak Persian, had no severe diabetes complications and no history of psychological disorders. The history of
psychological disorders was ascertained through patients’ medical files, taking history of any medications in this
regard. The study design was explained to all patients and informed consent was obtained. Volunteer patients
completed the Persian version of the questionnaires (CES-D and PHQ-9) and a psychiatrist interviewed them based
on Structured Clinical Interview (SCID) for DSM-IV criteria.
Results: Of the 185 patients, 43.2% were diagnosed as having Major Depressive Disorder (MDD) based on the
clinical interview, 47.6% with PHQ-9 and 61.62% with CES-D. The Area Under the Curve (AUC) for the total score of
PHQ-9 was 0.829 ± 0.30. A cut-off score for PHQ-9 of ≥ 13 provided an optimal balance between sensitivity
(73.80%) and specificity (76.20%). For CES-D the AUC for the total score was 0.861 ± 0.029. Optimal balance
between sensitivity (78.80%) and specificity (77.1%) was provided at cut-off score of ≥ 23.
Conclusions: It could be concluded that the PHQ-9 and CES-D perform well as screening instruments, but in
diagnosing major depressive disorder, a formal diagnostic process following the PHQ-9 and also the CES-D remains
essential.
Background
The quality of life in patients with various chronic disor-
ders, including diabetes has been directly affected by
depression [1,2]. Depression makes patients less likely to
manage their self-care regimens [3,4]. Based on a recent
systematic review, the prevalence of depression was signifi-
cantly higher in patients with Type 2 diabetes and it has
been shown that people with diabetes are more likely to
have higher rate of depression compared to their non dia-
betic counterparts [5].
Co-morbidity of depression and diabetes results in
higher HbA1c levels [6,7], increased number and severity
of complications and higher mortality rate [8-10]. More-
o v e r ,d e p r e s s i o ni np a t i e n t sw ith diabetes is associated
with increased rate of medical symptoms reporting and
health care seeking [10,11] more hospitalizations and
hospitalization days [12] and higher healthcare costs
[13,14] impaired patient-provider communication [15]
and lower patient satisfaction [16] are other adverse
consequences.
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populations is important to the treatment of depression
in this group and may improve diabetes management.
The gold standard for assessment of clinical depression
could be a standardized, structured patient interview that
yields clinical diagnoses that conform to Diagnostic and
Statistical Manual of Psychiatric Disorders, 4th edition
(DSM-IV) criteria. While time and cost restrict use of
this method for screening purpose, self-administered
questionnaires are easy to use and cost- effective. Several
questionnaires have been developed such as Beck
Depression Inventory [17], the Center for Epidemiologi-
cal Studies Depression (CESD) scale [18], the Patient
Health Questionnaire-9 [19] and the Center for Epide-
miologic Studies Depression Scale Revised (CESD-R)
which was recently created [20].
To our best knowledge, there are few studies that have
looked for utilizing questionnaires in screening for depres-
sion among patients with diabetes in Iran. Therefore the
aim of this study was to assess the efficacy and accuracy of
these tools, (CESD) and (PHQ-9), in comparison with clin-
ical interview in Iranian people with diabetes.
Methods
This cross-sectional study was conducted at Institute of
Endocrinology and Metabolism (IEM) affiliated to Tehran
University of Medical Sciences, Tehran, Iran. Ethics
approval was granted from the Ethics’ Board at IEM. Out-
patients who attended diabetes clinics at IEM were
recruited on a consecutive basis between February 2009
and July 2009. Inclusion criteria included patients with
type 2 diabetes who could fluently read and speak Persian,
had no severe diabetes complications and no history of
psychological disorders. The history of psychological dis-
orders was ascertained through patients’ medical files, tak-
ing history of any medications in this regard. The study
design was explained to all patients and informed consent
was obtained.
We employed two standard questionnaires, CES-D and
PHQ-9, for this study. The PHQ-9 focuses on the nine
signs and symptoms of depression from DSM-IV. The
PHQ-9 offers a categorical algorithm for the diagnosis of
depressive disorder. Major depression is diagnosed if 5 or
more of the 9 depressive symptoms criteria have been pre-
sent for at least “more than half the days” in the past
2 weeks (suicidal thoughts count if present at all) and one
of the symptoms is depressed mood or anhedonia. In addi-
tion, the sum score (0-27) is used for screening purposes
and for measuring depression severity. The cut-off point
that is most widely used to indicate a positive case for
depressive disorder is the sum score of 10 or higher [21].
CES-D is a 20-item questionnaire that assesses depressive
symptoms over the previous 7 days. We used Cut-off
points of 16 and 22 to define “likely depression” [18,21].
Using a standard ‘forward-backward’ translation
procedure, the English language version of the question-
naires (CES-D and PHQ-9) were translated into Persian
(Farsi). Then these questionnaires were piloted on 46
patients. The reliability of these questionnaires was mea-
sured by using Cronbach’s alpha (CES-D-Cronbach’s
Alpha = 0.92 and PHQ-9-Cronbach’s Alpha = 0.86).
The aims and details of the study were explained to
patients when attending clinic by a trained nurse.
Volunteer patients completed both questionnaires. Then
scheduled appointments were made with a psychiatrist
who was associate clinical professor of Tehran Psychia-
try Institute (TPI), in the same week as completing the
questionnaires. The psychiatrist was blind to results of
these questionnaires and she interviewed patients based
on Structured Clinical Interview (SCID) for DSM-IV
(Persian Translation and Cultural Adaptation) [22]. The
average duration of interview took between 20-40 min-
utes. The interview had implications only for research
proposal however after diagnosis of depression for each
patients, the psychiatrist started the necessary treatment
and/or any medications for them. In addition demo-
graphic and clinical information were gathered at the
time of administrating the questionnaires by that trained
nurse.
Statistical analysis
To determine the screening performance of the two
questionnaires in identifying patients with MDD and to
identify optimal cut-off scores, receiver operating char-
acteristic curve (ROC) analysis was used. The Area
Under the Curve (AUC) was calculated to quantify
screening ability. The AUC of the screening instrument
is evaluated by comparison with the AUC of the diago-
nal line, which represents classification by chance (AUC
= 0.50). The optimal cut-off score of the screening
instrument is selected by using the score that is closest
to the intersection of the ROC and the diagonal line
from the upper left to the lower right side of the graph.
Descriptive data are given as mean ± SD and percen-
tage. Comparison among subjects of groups was per-
formed by student’s t-test for continuous variables as
well as Chi- square test for frequency of dichotomous
variables. SPSS v.16 was used for statistical analyses.
A p < 0.05 was considered significant.
Results
Totally one hundred and eighty five patients com-
pleted the questionnaires and were interviewed by a
psychiatrist. Approximately fifty-two percent of the
patients were female. The mean age was 56.1(9.6)
years, the mean of duration of diabetes was 9.8(SD =
7.3) years, and average HbA1C was 8.1(SD = 1.92)
(Table 1).
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Page 2 of 6Table 1 Demographic characteristics of study sample who had screened for depression by PHQ-9 and CES-D and Clinical Interview
characteristic Total sample Clinical interview PHQ-9 CES-D (score ≥ = 16) CES-D (score ≥ = 22)
n = 185 (%) MDD
n=8 0
No MDD
n = 105
P MDD
n=8 8
No MDD
n=9 7
P MDD
n = 114
No MDD
n=7 1
P MDD
n=9 0
No MDD
n=9 5
P
Gender
Male 89(48.1) 33(41.2) 56(53.3) P = 0.10 30(34.1) 59(60.8) P < 0.001 42(36.8) 47(66.2) P < 0.001 31( 34.4) 58(61.1) P < 0.001
Female 96(51.9) 47(58.8) 49(46.7) 58(65.9) 38(39.2) 72(63.2) 24(33.8) 59(65.6) 37(38.9)
Education
< 8 grades 100(54.1) 43(53.8) 57(54.3) P = 0.94 54(61.4) 46(47.4) P = 0.05 66(57.9) 34(47.9) P = 0.18 53(58.9) 47(49.5) P = 0.19
≥ 8grades 85(45.9) 37(46.2) 48(45.7) 34(38.6) 51(52.6) 48(42.1) 37(52.1) 37(41.1) 48(50.5)
Insurance
Yes 168(92.3) 74(93.7) 94(91.3) P = 0.54 80(90.9) 88(93.6) P = 0.49 104(92.9) 64(91.4) P = 0.72 83(92.2) 85(92.4) P = 0.96
No 14(7.7) 5(6.3) 9(8.7) 8(9.1) 6(6.4) 8(7.1) 6(8.6) 7(7.8) 7(7.6)
Medication
Oral 121(67.6) 50(64.9) 71(69.6) P = 0.36 54(62.1) 67(72.8) P = 0.30 74(66.1) 47(70.1) P = 0.83 54(60.7) 67(74.4) P = 0.14
Insulin 25(14) 14(18.2) 11(10.8) 14(16.1) 11(12.0) 16(14.3) 9(13.4) 15(16.9) 10(11.1)
Oral & Insulin 34(18.4) 13(16.9) 20(19.6) 19(21.8) 14(15.2) 22(19.6) 11(16.4) 20(22.5) 13(14.4)
Family income
low 95(51.4) 43(53.8) 52(49.5) P = 0.56 49(55.7) 46(47.4) P = 0.26 63(55.3) 32(45.1) P = 0.17 49(54.4) 46(48.4) P = 0.41
middle-high 90(48.6) 37(46.2) 53(50.5) 39(44.3) 51(52.6) 51(44.7) 39(54.9) 41(45.6) 49(51.6)
Age (mean ± SD) 56.17 ± 9.60 54.38 ± 9.16 57.53 ± 9.74 P = 0.02 54.88 ± 10.13 57.34 ± 8.98 P = 0.08 55.87 ± 10.31 56.65 ± 8.37 P = 0.59 55.14 ± 10.32 57.14 ± 8.81 P = 0.15
HbA1C 8.10 ± 1.92 8.14 ± 1.98 8.06 ± 1.89 P = 0.80 8.32 ± 2.01 7.91 ± 1.84 P = 0.18 8.25 ± 1.99 7.86 ±1.79 P = 0.21 8.26 ± 2.01 7.95 ± 1.84 P = 0.32
BMI 28.33 ± 4.72 28.52 ± 4.33 28.20 ± 5.00 P = 0.68 28.55 ± 4.56 28.16 ± 4.87 P = 0.60 28.60 ± 4.68 27.92 ± 4.80 P = 0.38 28.58 ± 4.35 28.12 ± 5.03 P = 0.55
Diabetes duration
(year ± SD )
9.83 ± 7.38 11.02 ± 7.26 8.93 ± 7.37 P = 0.05 9.22 ± 6.93 10.38 ± 7.75 P = 0.29 9.91 ± 7.06 9.70 ± 7.91 P = 0.85 9.77 ± 6.87 9.88 ± 7.86 P = 0.91
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6Of the 185 patients, eighty (43.2%) were diagnosed as
having Major Depressive Disorder (MDD) based on the
clinical interview. Comparing those with MDD and with-
out MDD, the former found to be younger and this dif-
ference was statistically significant (P = 0.02). These two
groups were not different in other variables (Table 1).
The PHQ-9 diagnosed 88 (47.6%) patients with MDD.
Women with depression were more dominant (P < 0.001).
On the CES-D, patients with MDD were found to be
114 (61.62%) and 90 (48.64%) with cut-points of ≥ 16 and
≥ 22, respectively. By considering both of cut-points,
MDD was identified more in female than in male and
this difference was statistically significant (P < 0.001).
We compared the screening performance of each
questionnaire with clinical interview (Table 2). The abil-
ity of the questionnaires to screen for MDD according
to DSM-IV was assessed by using the area under the
ROC (AUC) (Figure 1).
The AUC for the total score of PHQ-9 was 0.829 ±
0.30, which is significantly higher than the diagonal line
(P < 0.001). A cut-off score for PHQ-9 of ≥13 provided
an optimal balance between sensitivity (73.80%) and spe-
cificity (76.20%). For CES-D the AUC for the total score
was 0.861 ± 0.029 which is significantly higher (p <
0.001) than the diagonal line as well. Optimal balance
between sensitivity (78.80%) and specificity (77.1%) was
provided at cut-off score of ≥ 23.
The reliability of these questionnaires was measured
by using Cronbach’s alpha (CES-D Cronbach’sa l p h a=
0.936 and PHQ-9 Cronbach’s alpha = 0.873).
Discussion
In this study, 43.2% of patients were diagnosed to have
MDD by clinical interview. A recent systematic review esti-
mated the prevalence of depression in adults with Type 2
diabetes compared to those without diabetes and the pre-
valence rate of depression was nearly twice as high in
patients with diabetes compared to those without. (OR =
1.6, 95% CI = 1.5-1.7) [5]. In line with other studies, a
report from Iran indicated that rate of depression in
patients with diabetes was higher than those without dia-
betes (OR = 2.1, 95% CI 1.4-3.2) [23]. Other reports from
Iran using different tools for depression showed high rates
of depression in people with diabetes in Iranian population
[24,25].
Anderson and colleagues stated that the prevalence of
depression varied systematically as a function of the
method used to identify depression cases and the study
design. Furthermore, in both controlled and uncon-
trolled studies, depression rates were approximately two
to three times higher in studies that used self-report
measures versus diagnostic interview [26].
In our sample, rate of MDD was higher compared to
previous findings [5] which could be explained by the fact
that the specialized diabetes center may have attracted
patients who had more problems, including more depres-
sion, than the non-referral patients with diabetes.
The main objectives of our study were to determine
the accuracy of PHQ-9 and CES-D questionnaires in
screening for major depressive disorder in Iranian
patients with type 2 diabetes.
Sensitivity and specificity of the PHQ-9 in this study
differ from previous accuracy studies [27,28] due to dif-
ferent prevalence of MDD in the populations. In our
sample, applying algorithmic approach led to almost
similar LRs as using scores. Considering these likelihood
ratios, the PHQ-9 generates small to moderate shifts in
pre- to posttest probability [29] of MDD in patients
with diabetes indicating that the PHQ-9 might not be a
proper tool to be used as a diagnostic instrument in a
population at high risk of depression. It can be used in
general practice for case finding, but should always be
followed by diagnostic interview. Wittkampf and collea-
gues reported similar findings as our study [27].
Also the CES-D has different sensitivity and specificity
compared to previous studies [21]. In our study, test
characteristics of the CES-D are almost similar to the
PHQ-9, indicating that the likelihood ratios alter postt-
est probability of MDD to a small to moderate degree.
Therefore CES-D seems insufficient clinical tool for
diagnosis of MDD in patients with diabetes.
Another important issue is that exclusion criteria in
diagnosis of MDD are not included in the question-
naires so further assessment by clinical interview seems
to be reasonable.
In this study, the PHQ-9 had AUC = 0.829 ± 0.30 and
the CES-D had the AUC = 0.861 ± 0.029. However this
difference was not statistically significant (P = 0.153).
Therefore it seems no preference of employing one of
these questionnaires.
Table 2 Diagnostic performance of questionnaires for detection of major depressive disorder
Sensitivity % Specificity % + LR - LR
PHQ-9 algorithm 77.5 (66.5-85.7) 75.2(65.6-82.9) 3.1(2.1-4.4) 0.2(0.1-0.4)
PHQ-9(score ≥ 10) 83.8(73.4-90.7) 65.7(55.7-74.5) 2.4(1.8-3.2) 0.2(0.1-0.4)
PHQ-9(score ≥ 13) 73.8(62.5-82.6) 76.2(66.6-83.7) 3.1(2.1-4.4) 0.3(0.2-0.5)
CES-D(score ≥ 16) 90 (80.7-95.2) 60 (49.9-69.2) 2.2(1.7-2.8) 0.2(0.0-0.3)
CES-D(score ≥ 22) 82.5(72.-89.7) 77.1(67.7-84.5) 3.6(2.5-5.2) 0.2(0.1-0.3)
CES-D(score ≥ 23) 78.8(67.8-86.7) 77.1(67.7-84.5) 3.4(2.3-4.9) 0.2(0.1-0.4)
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Page 4 of 6Based on our experience from this study the depres-
sion symptoms of patients could be demonstrated easily
and better by items of the CES-D. However, the PHQ-9
includes fewer items and it would be less time consum-
ing to complete it.
The finding of this study has demonstrated that these
questionnaires are valid and reliable in Persian language
therefore they can be employed in Iranian population.
Conclusions
It could be concluded that the PHQ-9 and CES-D
(Farsi/Persian versions) perform well as screening
instruments, but in diagnosing major depressive disor-
der, a formal diagnostic process following the PHQ-9
and also CES-D remains essential.
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